The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder Update

4 Oct 2018 15:20

RNS Number : 0345D
Ranger Direct Lending Fund PLC
04 October 2018
 

4 October 2018

RANGER DIRECT LENDING FUND PLC (or the "Company")

Shareholder update

The Company's Half Yearly Financial Report Announcement dated 24 September 2018 explained that the Company has commenced a process of the orderly realisation of assets and anticipates being in a position to commence capital returns to holders of Ordinary Shares in the Company in the coming months. In addition, the Company has commenced discussions with holders of the zero dividend preference shares (the "ZDP Shares") issued by the Company's subsidiary Ranger Direct Lending ZDP plc ("Ranger ZDP").

The rights of the holders of the ZDP Shares are set out in the articles of association of Ranger ZDP (the "Ranger ZDP Articles") and the obligations of the Company to Ranger ZDP in relation to the ZDP Shares are set out in a loan agreement (the "Loan Agreement") and an undertaking (the "Undertaking") between the Company and Ranger ZDP. Subject to what is set out below in relation to page 16 of the prospectus published by Ranger ZDP dated 26 July 2016 (the "ZDP Prospectus"), those documents do not provide a mechanism specifically designed to implement a winding down of the Company and Ranger ZDP prior to 31 July 2021 (the "ZDP Repayment Date"), which is the date on which the holders of the ZDP shares would be entitled to be paid the Final Capital Entitlement (as defined in the Ranger ZDP Articles).

The ZDP Prospectus stated (on page 17) that the different rights and expectations of the holders of Ordinary Shares in the Company and the holders of ZDP Shares may give rise to conflicts of interest between them. The directors of the Company intend to act in a manner which they consider to be fair and equitable having regard to the entitlements of the shareholders of the Company, the Company's obligations to Ranger ZDP and the entitlements of the holders of ZDP Shares under the Ranger ZDP Articles.

It was also stated, on page 16 of ZDP Prospectus, that if the Company is wound up prior to the ZDP Repayment Date, including where a Continuation Vote is not approved by holders of ZDP shares following a breach by the Company of the Loan Agreement or the Undertaking, holders of the ZDP shares will only be entitled to receive their accrued capital entitlement to the date of the resulting winding up of Ranger ZDP.

Ranger ZDP is a Company to which the UK City Code on Takeovers and Mergers (the "City Code") applies. However, only the ordinary shares in Ranger ZDP (all of which are owned by the Company) are securities carrying voting rights for the purposes of the City Code. As a result, any acquisition of or offer for ZDP Shares would not be subject to the City Code.

Subject to sufficient cash being available to the Company as a result of progress in the realisation of the Company's assets, the Company will seek to agree with holders of ZDP Shares a price at which their ZDP Shares can be retired (which is expected to be conducted by way of the acquisition of ZDP Shares by the Company). At this stage, the Company has indicated to holders of ZDP Shares a willingness to pay amounts of between 112.5p and 113.5p per ZDP Share. The dialogue with holders of ZDP Shares and any acquisitions of ZDP Shares by the Company may or may not lead to an offer being made by the Company to acquire all of the ZDP Shares.

The Company would expect to exercise the voting rights of any ZDP Shares acquired by it to vote against any Continuation Resolution (as defined in the Ranger ZDP Articles) if a vote on such a resolution is triggered under the terms of the Loan Agreement or the Undertaking in the context of the winding down of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact:

Link Company Matters Limited

Secretary

 

+44 (0)1392 477 576

 

LEI: 549300VGZSKYQ7C2U221

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSASRWOARRAA
Date   Source Headline
25th Jan 202111:50 amRNSPortfolio Update
12th Jan 20211:12 pmRNSResult of General Meeting
23rd Dec 20207:00 amRNSPortfolio Update
21st Dec 20204:59 pmRNSPublication of Delisting Circular and Notice of GM
21st Dec 20204:59 pmRNSHolding(s) in Company
10th Dec 20205:20 pmRNSDividend Declaration
27th Nov 20205:37 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSChange of AIFM and intention to delist
24th Nov 202010:31 amRNSPortfolio Update
26th Oct 20209:56 amRNSPortfolio Update
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNSPortfolio Update
22nd Sep 20207:00 amRNSHalf-year Report
16th Sep 20204:34 pmRNSDirector Declaration
9th Sep 202012:31 pmRNSPortfolio Update
20th Aug 202012:07 pmRNSSecond Price Monitoring Extn
20th Aug 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 20209:43 amRNSPortfolio Update
9th Jul 202011:16 amRNSDirector Declaration
30th Jun 20203:37 pmRNSResult of AGM
24th Jun 20202:48 pmRNSPortfolio Update
8th Jun 20204:41 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSAnnual Financial Report
28th May 20206:00 pmRNSRevised Publication Date For The Annual Report
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:21 amRNSPortfolio Update
30th Apr 20202:41 pmRNSPublication Date for Annual Report
27th Apr 20209:58 amRNSDisclosure of Rights Attaching to Equity Shares
7th Apr 20207:00 amRNSDividend Declaration
2nd Apr 202010:54 amRNSResignation of Director
30th Mar 20202:02 pmRNSPortfolio Update
16th Mar 20207:00 amRNSPrinceton Update
11th Mar 20207:00 amRNSPortfolio Update
20th Feb 20205:06 pmRNSPrinceton Update
3rd Feb 20207:00 amRNSPortfolio Update
17th Jan 20209:44 amRNSHolding(s) in Company
10th Jan 20204:41 pmRNSPrinceton Update
9th Jan 202012:11 pmRNSDividend Declaration
31st Dec 201911:18 amRNSUpdate - Standstill Agreement
24th Dec 201910:11 amRNSHolding(s) in Company
23rd Dec 20194:49 pmRNSPortfolio Update
10th Dec 201910:12 amRNSDirector Declaration
26th Nov 201911:29 amRNSPortfolio Update
26th Nov 20197:00 amRNSDividend Declaration
6th Nov 201910:07 amRNSPortfolio Update
28th Oct 20194:50 pmRNSDirector Declaration
24th Oct 201911:21 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.